“As a result of Lewis solely complained of regulatory, reasonably than fraudulent, violations in his inside communications with AbbVie, the corporate had no cause to assume Lewis’s considerations revolved across the False Claims Act. Extra merely, AbbVie couldn’t have retaliated in opposition to Lewis as a fraud whistleblower as a result of he by no means blew the whistle on fraud, U.S. Courtroom of Appeals for the Seventh Circuit Choose Joshua P. Kolar mentioned.
Trending
- Loaded fries, tacos and perfect pies: eight crowd-pleasing recipes for footy finals weekend | Australian food and drink
- Making a Monster Mash: How the Blair Brothers Scored ‘The Toxic Avenger’
- ‘Maggots raining down’: survey lays bare dire state of courts in England and Wales | England
- Meta Will Open Three New Retail Outlets in the Lead Up to Christmas
- The Most Followed Gen Z Celebrities on Instagram [Infographic]
- YouTube is fine with creators spreading misinformation, actually
- Business cannot ‘carry cost’ of fixing UK workforce health crisis, warns BCC head
- Trump administration fires immigration judges, even as it seeks to hire more of them